Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al

J Clin Oncol. 2016 Aug 10;34(23):2804-5. doi: 10.1200/JCO.2016.67.9449. Epub 2016 Jun 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Androgen Antagonists / adverse effects*
  • Humans
  • Male
  • Risk

Substances

  • Androgen Antagonists